Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

GSA Capital Partners LLP lifted its holdings in TELA Bio, Inc. (NASDAQ:TELA – Free Report) by 398.8% during the 3rd quarter, according to its most recent filing with the Securities & Exchange ...

Caitlin Cronin, an analyst from Canaccord Genuity, maintained the Buy rating on TELA Bio (TELA – Research Report). The associated price target remains the same with $12.00. Don't Miss our Black Friday ...

TELA Bio, Inc. (NASDAQ: TELA) announced its participation in Piper Sandler’s 36th Annual Healthcare Conference, a premier ...

MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today ...

Continua preso o casal suspeito de envolvimento na morte do próprio filho, de apenas 53 dias, no Parque Vicente Leporace, em ...

TELA Bio, Inc. (TELA), a company specializing in soft tissue preservation and restoration, has reported a robust financial performance in its Third Quarter 2024 Earnings Conference Call. The company's ...

TELA Bio, Inc. (TELA), a company specializing in soft tissue preservation and restoration, has reported a robust financial performance in its Third Quarter 2024 Earnings Conference Call.

Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and ...

In the latest quarter, 6 analysts provided ratings for TELA Bio (NASDAQ:TELA), showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings ...